65,437 trials
Diabetes Mellitus, Type 1 · Noncompliance, Patient
Primary: Change in Hemoglobin A1c From Baseline to 3 Months — -0.9 percent — p=0.03
Bipolar Disorder · Transcranial Magnetic Stimulation
Primary: Affective Multisource Interference Task - Reaction Time During Negative Interference Trials — 733.45; 720.58; 723.09; 698.17 Reaction Time (ms) — p=<0.0001
Spinal and Bulbar Muscular Atrophy · Kennedy's Disease
Primary: Analysis of Thigh and Total Lean Muscle Volume (LMV) [A+B+C] — 4.1402; 3.8580; -0.0871; -0.1042 cm³
Sedation
Primary: Percentage of Time Sedation Depth is Maintained Within the Target Range, in Absence of Rescue Sedation, as Assessed According to the RASS Scale, in Isoflurane- vs…
Colorectal Neoplasms · Microsatellite Instability
Primary: Overall Response Rate (ORR) — 0 % of participants
Chronic Pain · Opioid Use Disorder · Opioid Misuse
Primary: Feasibility of the Intervention — 25 Participants
Alzheimer Disease or Associated Disorder
Primary: Percent of Eligible Emergency Department Visits With Completed Outreach — 547; 304 Emergency Department Visits
Dry Eye
Primary: Change in Ocular Surface Disease Index (OSDI) — 25.8; 25.8; 24.8; 12.8 score on a scale
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Primary: Change From Baseline in pVO2 at Week 24 — 1.76; 0.02 mL/kg/min — p=<0.0001
Carcinoma, Non-Small-Cell Lung
Primary: Incidence and Grade of Adverse Events (AEs) and Serious Adverse Events (SAEs) — 130; 43; 25; 12 participants
Soft-tissue Sarcoma
Primary: Count of Patients With Dose Limiting Toxicity — 0 Participants
Lymphedema · Lymphedema of Face · Lymphedema, Secondary
Primary: Internal Lymphedema - Endoscopy — -0.12; -0.06; -0.21; -0.16 Score on a scale
Hemodialysis · Intradialytic Hypotension
Primary: Prevent Intradialytic Hypotension — 1089; 2511 HD sessions
Venous Thromboembolism
Primary: Percentage of Participants With Confirmed, Adjudicated Venous Thromboembolism (VTE) — 7.1; 17.2 percentage of participants
Squamous Cell Carcinoma of the Head and Neck
Primary: Disease Free Survival (DSF) Time- 2 Year Estimate — 48; 57 days